HEOR NEWS
Health Technology Assessment: First Joint Clinical Assessments Begin (EU Health and Food Safety Directorate General)
The first 2 joint clinical assessments for medicinal products have started under the Health Technology Assessment Regulation (EU 2021/2282)—the studies are for a pediatric cancer treatment and an advanced therapy medicinal product to treat skin cancer.
Read more
White Paper on Advancing Environmental Sustainability Through Health Technology Assessment (International Network of Agencies for Health Technology Assessment)
The paper aims to advance the discussion of the potential readiness and role for health technology assessment agencies to integrate environmental impact assessment into their evaluations, and to inspire these groups to work together to reduce the environmental footprint of healthcare and support health systems to deliver high-quality, cost-effective, and environmentally sustainable care.
Read more
Top 10 Research Priorities in Global Burns Care: Findings From the James Lind Alliance Global Burns Research Priority Setting Partnership (The Lancet Global Health)
Researchers say the main strength of this priority-setting partnership is the breadth of its international engagement and multisource data collection, believing it is the most international such James Lind Alliance exercise to date, and it could provide valuable lessons for future prioritization work in other fields.
Read more
Estimated Undertreatment of Carbapenem-resistant Gram-negative Bacterial Infections in 8 Low-income and Middle-income Countries: A Modeling Study (The Lancet Infectious Diseases)
In looking at 8 selected countries, researchers estimated that Infections caused by CRGN bacteria are likely to be significantly undertreated in LMICs and recommend improved access to diagnostics and antibiotics, strengthening of health systems, and research to identify gaps in the treatment pathway are needed.
Read more
Healthcare-associated Infections, a Threat to Residents of Long-term Care Facilities in Europe (European Centre for Disease Prevention and Control)
A new ECDC survey reveals that 3.1% of the residents in long-term care facilities had at least one healthcare-associated infection at the time of the study, pointing to serious gaps in infection prevention and control measures, as well as antimicrobial stewardship in elder care facilities.
Read more
Medical Journals Coming Under Scrutiny From Trump Administration (Harvard T.H. Chan School of Public Health)
After 2 medical journals received letters from a top US attorney asking for responses to questions about alleged bias, scientists are expressing concern about potential Trump administration interference in the journals’ work.
Read more
Robert F. Kennedy Jr Asks Centers for Disease Control and Prevention for New Measles Treatment Guidance Amid His Unfounded Claims (CBS News)
Health and Human Services Secretary Robert F. Kennedy Jr. will ask the CDC to develop new guidance for treating measles with drugs and vitamins, an HHS spokesperson said.
Read more
Trump Administration Slashes Research Into LGBTQ Health (New York Times)
The Times found that more than $800 million in grants cancelled through early May addressed the health of sexual and gender minority groups, including studies of cancers and viruses that tend to affect members of these groups, and the cancellations will set back efforts to defeat a resurgence of sexually transmitted infections.
Read more
Scientists Question National Institutes of Health Project’s Use of 20th Century Technology to Make a Universal Flu Vaccine (STAT)
As the Department of Health and Human Services announced that it was investing half a billion dollars on an NIH project to develop a vaccine platform for pathogens that could trigger pandemics, scientists are puzzled as to why the project is using the whole killed viruses method pioneered in the 20th century and overtaken by newer, more nimble production processes.
Read more
Canada’s Drug Agency Announces New 5-year Strategic Plan (Canada’s Drug Agency)
The first strategic plan for the agency aims to power evidence-driven drug, health technology, and health system decisions supported by guiding principles of excellence, agility, partnership, inclusion, diversity, equity, accessibility, and integrity.
Read more
